AbCellera Biologics, Inc. (ABCL)
3.67
+0.08
(+2.23%)
USD |
NASDAQ |
Dec 09, 16:00
3.69
+0.02
(+0.54%)
After-Hours: 20:00
AbCellera Biologics Market Cap: 1.099B for Dec. 9, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Achieve Life Sciences, Inc. | 248.87M |
| Oncolytics Biotech, Inc. | 104.02M |
| Aurinia Pharmaceuticals, Inc. | 2.044B |
| Edesa Biotech, Inc. | 12.44M |
| Lexaria Bioscience Corp. | 25.23M |
Market Cap Related Metrics
| PS Ratio | 30.93 |
| Price to Book Value | 1.140 |
| Price | 3.67 |
| Earnings Yield | -15.70% |